Welcome to LookChem.com Sign In|Join Free

CAS

  • or

33005-95-7

Post Buying Request

33005-95-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

33005-95-7 Usage

Chemical Properties

White or almost white, crystalline powder.

Originator

Surgam,Roussel,France,1975

Uses

Antiinflammatory;Cyclooxygenase inhibitor

Definition

ChEBI: An aromatic ketone that is thiophene substituted at C-2 by benzoyl and at C-4 by a 1-carboxyethyl group.

Manufacturing Process

A mixture of 10.3 g of thiophene-2α-methylacetic acid [prepared by process of Bercot-Vatteroni, et al., Bull. Soc. Chim. (1961) pp. 1820-21], 11.10 g of benzoyl chloride and a suspension of 23.73 g of aluminum chloride in 110 cc of chloroform was allowed to stand for 15 minutes and was then poured into a mixture of ice and hydrochloric acid. The chloroform phase was extracted with a 10% aqueous potassium carbonate solution and the aqueous alkaline phase was acidified with N hydrochloric acid and was then extracted with ether. The ether was evaporated off and the residue was crystallized from carbon tetrachloride to obtain a 54% yield of 5-benzoyl-thiophene-2α-methylacetic acid melting at 83°C to 85°C. The product occurred in the form of colorless crystals soluble in dilute alkaline solutions, alcohol and ether and insoluble in water.

Therapeutic Function

Antiinflammatory

Clinical Use

#N/A

Drug interactions

Potentially hazardous interactions with other drugs ACE inhibitors and angiotensin-II antagonists: antagonism of hypotensive effect; increased risk of nephrotoxicity and hyperkalaemia. Analgesics: avoid concomitant use of 2 or more NSAIDs, including aspirin (increased side effects); avoid with ketorolac (increased risk of side effects and haemorrhage). Antibacterials: possibly increased risk of convulsions with quinolones. Anticoagulants: effects of coumarins and phenindione enhanced; possibly increased risk of bleeding with heparins, dabigatran and edoxaban - avoid long term use with edoxaban. Antidepressants: increased risk of bleeding with SSRIs and venlaflaxine. Antidiabetic agents: effects of sulphonylureas enhanced. Antiepileptics: possibly increased phenytoin concentration. Antivirals: increased risk of haematological toxicity with zidovudine; concentration increased by ritonavir. Ciclosporin: may potentiate nephrotoxicity. Cytotoxics: reduced excretion of methotrexate; increased risk of bleeding with erlotinib. Diuretics: increased risk of nephrotoxicity; antagonism of diuretic effect; hyperkalaemia with potassium-sparing diuretics. Lithium: excretion decreased. Pentoxifylline: increased risk of bleeding. Tacrolimus: increased risk of nephrotoxicity.

Metabolism

Sparingly metabolised in the liver to two inactive metabolites. Excretion of tiaprofenic acid and its metabolites are mainly in the urine in the form of acyl glucuronides; some is excreted in the bile.

Check Digit Verification of cas no

The CAS Registry Mumber 33005-95-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,0,0 and 5 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 33005-95:
(7*3)+(6*3)+(5*0)+(4*0)+(3*5)+(2*9)+(1*5)=77
77 % 10 = 7
So 33005-95-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H12O3S/c1-9(14(16)17)11-7-8-12(18-11)13(15)10-5-3-2-4-6-10/h2-9H,1H3,(H,16,17)

33005-95-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (T3175)  Tiaprofenic Acid  >98.0%(GC)(T)

  • 33005-95-7

  • 25mg

  • 1,190.00CNY

  • Detail
  • TCI America

  • (T3175)  Tiaprofenic Acid  >98.0%(GC)(T)

  • 33005-95-7

  • 100mg

  • 3,390.00CNY

  • Detail

33005-95-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Tiaprofenic Acid

1.2 Other means of identification

Product number -
Other names 2-(5-Benzoylthiophen-2-yl)propanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:33005-95-7 SDS

33005-95-7Synthetic route

2-thiophen-2-yl-propionic acid
54955-39-4

2-thiophen-2-yl-propionic acid

benzoyl chloride
98-88-4

benzoyl chloride

tiaprofenic acid
33005-95-7

tiaprofenic acid

Conditions
ConditionsYield
With aluminum (III) chloride In ethyl acetate at 20℃; for 5h; Cooling with ice;94%
With aluminum (III) chloride In ethyl acetate at 20℃; for 5.5h; Friedel-Crafts Acylation; Cooling with ice;94%
With aluminum (III) chloride In ethyl acetate at 20℃; for 5h; Cooling with ice;94%
With zinc(II) oxide In neat (no solvent) at 20℃; Friedel-Crafts Acylation;93.5%
With zinc diacetate at 20 - 40℃; for 0.833333h;92%
methyl α-methylthio-α-(5-benzoyl-thien-2-yl)-propionate
67355-14-0

methyl α-methylthio-α-(5-benzoyl-thien-2-yl)-propionate

sodium thiomethoxide
5188-07-8

sodium thiomethoxide

tiaprofenic acid
33005-95-7

tiaprofenic acid

Conditions
ConditionsYield
In methanol; dichloromethane; water68%
2-Acetylthiophene
88-15-3

2-Acetylthiophene

tiaprofenic acid
33005-95-7

tiaprofenic acid

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: sodium tetrahydroborate; ethanol / 6 h / 20 °C
2: thionyl chloride / 3 h / 70 °C
3: potassium carbonate / acetonitrile / 10 h / 70 °C / Inert atmosphere
4: sulfuric acid; acetic acid / 6 h / 125 °C
5: aluminum (III) chloride / ethyl acetate / 5 h / 20 °C / Cooling with ice
View Scheme
2-chloro-2-(2-thienyl)ethane
28612-98-8

2-chloro-2-(2-thienyl)ethane

tiaprofenic acid
33005-95-7

tiaprofenic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: potassium carbonate / acetonitrile / 10 h / 70 °C / Inert atmosphere
2: sulfuric acid; acetic acid / 6 h / 125 °C
3: aluminum (III) chloride / ethyl acetate / 5 h / 20 °C / Cooling with ice
View Scheme
Multi-step reaction with 3 steps
1: potassium carbonate / acetonitrile / 10 h / 70 °C / Inert atmosphere
2: acetic acid; sulfuric acid / 6 h / 125 °C
3: aluminum (III) chloride / ethyl acetate / 5 h / 20 °C / Cooling with ice
View Scheme
1-(thien-2-yl)ethanol
115510-91-3

1-(thien-2-yl)ethanol

tiaprofenic acid
33005-95-7

tiaprofenic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: thionyl chloride / 3 h / 70 °C
2: potassium carbonate / acetonitrile / 10 h / 70 °C / Inert atmosphere
3: sulfuric acid; acetic acid / 6 h / 125 °C
4: aluminum (III) chloride / ethyl acetate / 5 h / 20 °C / Cooling with ice
View Scheme
Multi-step reaction with 4 steps
1: thionyl chloride / 3 h / 70 °C
2: potassium carbonate / acetonitrile / 10 h / 70 °C / Inert atmosphere
3: acetic acid; sulfuric acid / 6 h / 125 °C
4: aluminum (III) chloride / ethyl acetate / 5 h / 20 °C / Cooling with ice
View Scheme
rac-2-(thiophen-2-yl)propanenitrile
88701-59-1

rac-2-(thiophen-2-yl)propanenitrile

tiaprofenic acid
33005-95-7

tiaprofenic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sulfuric acid; acetic acid / 6 h / 125 °C
2: aluminum (III) chloride / ethyl acetate / 5 h / 20 °C / Cooling with ice
View Scheme
2-Methylthiophene
554-14-3

2-Methylthiophene

tiaprofenic acid
33005-95-7

tiaprofenic acid

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: dibenzoyl peroxide; N-Bromosuccinimide / chloroform / 20 - 70 °C
2: potassium carbonate / acetonitrile / 6 h / 70 °C
3: potassium carbonate; tetrabutylammomium bromide / 7 h / 130 °C
4: acetic acid; sulfuric acid / 6 h / 125 °C
5: aluminum (III) chloride / ethyl acetate / 5.5 h / 20 °C / Cooling with ice
View Scheme
2-thenyl bromide
45438-73-1

2-thenyl bromide

tiaprofenic acid
33005-95-7

tiaprofenic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: potassium carbonate / acetonitrile / 6 h / 70 °C
2: potassium carbonate; tetrabutylammomium bromide / 7 h / 130 °C
3: acetic acid; sulfuric acid / 6 h / 125 °C
4: aluminum (III) chloride / ethyl acetate / 5.5 h / 20 °C / Cooling with ice
View Scheme
2-cyanomethylthiophene
20893-30-5

2-cyanomethylthiophene

tiaprofenic acid
33005-95-7

tiaprofenic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: potassium carbonate; tetrabutylammomium bromide / 7 h / 130 °C
2: acetic acid; sulfuric acid / 6 h / 125 °C
3: aluminum (III) chloride / ethyl acetate / 5.5 h / 20 °C / Cooling with ice
View Scheme
Multi-step reaction with 3 steps
1: potassium carbonate; tetrabutylammomium bromide / 7 h / 130 °C
2: sulfuric acid; acetic acid / 6 h / 125 °C
3: zinc diacetate / 0.83 h / 20 - 40 °C
View Scheme
2-Chloromethylthiophene
765-50-4

2-Chloromethylthiophene

tiaprofenic acid
33005-95-7

tiaprofenic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: potassium carbonate / acetonitrile / 10 h / 70 °C
2: potassium carbonate; tetrabutylammomium bromide / 7 h / 130 °C
3: sulfuric acid; acetic acid / 6 h / 125 °C
4: zinc diacetate / 0.83 h / 20 - 40 °C
View Scheme
thiophene-2-carbaldehyde
98-03-3

thiophene-2-carbaldehyde

tiaprofenic acid
33005-95-7

tiaprofenic acid

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: tetrahydrofuran / 5.5 h / 50 °C
2: thionyl chloride / 3 h / 70 °C
3: potassium carbonate / acetonitrile / 10 h / 70 °C / Inert atmosphere
4: acetic acid; sulfuric acid / 6 h / 125 °C
5: aluminum (III) chloride / ethyl acetate / 5 h / 20 °C / Cooling with ice
View Scheme
tiaprofenic acid
33005-95-7

tiaprofenic acid

(5-ethyl-2-thienyl)phenylmethanone
6933-26-2

(5-ethyl-2-thienyl)phenylmethanone

Conditions
ConditionsYield
In methanol at 20℃; for 24h; Irradiation;96%
With β‐cyclodextrin In phosphate buffer pH=7.2; Quantum yield; UV-irradiation;
In aq. phosphate buffer pH=7.4; Mechanism; UV-irradiation;
methanol
67-56-1

methanol

tiaprofenic acid
33005-95-7

tiaprofenic acid

A

(5-ethyl-2-thienyl)phenylmethanone
6933-26-2

(5-ethyl-2-thienyl)phenylmethanone

B

2-benzoyl-5-acetylthiophene
5912-44-7

2-benzoyl-5-acetylthiophene

C

2-Benzoyl-5-(1-hydroxyethyl)thiophene
143379-91-3

2-Benzoyl-5-(1-hydroxyethyl)thiophene

D

[5-(1-Methoxy-ethyl)-thiophen-2-yl]-phenyl-methanone
143381-62-8

[5-(1-Methoxy-ethyl)-thiophen-2-yl]-phenyl-methanone

Conditions
ConditionsYield
With oxygen at 20℃; for 24h; Product distribution; Mechanism; Irradiation; also in the presence of O2;A n/a
B 94%
C n/a
D n/a
tiaprofenic acid
33005-95-7

tiaprofenic acid

A

(5-ethyl-2-thienyl)phenylmethanone
6933-26-2

(5-ethyl-2-thienyl)phenylmethanone

B

2-benzoyl-5-acetylthiophene
5912-44-7

2-benzoyl-5-acetylthiophene

C

2-Benzoyl-5-(1-hydroxyethyl)thiophene
143379-91-3

2-Benzoyl-5-(1-hydroxyethyl)thiophene

Conditions
ConditionsYield
With oxygen In methanol at 20℃; for 24h; Irradiation;A n/a
B 94%
C n/a
With sodium dodecyl-sulfate In water Product distribution; Further Variations:; Reagents; Irradiation;
tyrosamine
51-67-2

tyrosamine

tiaprofenic acid
33005-95-7

tiaprofenic acid

N1-(4-hydroxyphenethyl)-2-(5-benzoyl-2-thienyl)propanamide

N1-(4-hydroxyphenethyl)-2-(5-benzoyl-2-thienyl)propanamide

Conditions
ConditionsYield
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; triethylamine In N,N-dimethyl-formamide at 20℃; pH=9.0 - 9.5;86%
tiaprofenic acid
33005-95-7

tiaprofenic acid

N-(pyren-1-ylmethyl)acetamide
263237-56-5

N-(pyren-1-ylmethyl)acetamide

N1-(1-pyrenylmethyl)-2-(5-benzoyl-2-thienyl)propanamide

N1-(1-pyrenylmethyl)-2-(5-benzoyl-2-thienyl)propanamide

Conditions
ConditionsYield
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; triethylamine In N,N-dimethyl-formamide pH=9.0 - 9.5;85%
tiaprofenic acid
33005-95-7

tiaprofenic acid

(α)-3-cholestanol
18769-46-5

(α)-3-cholestanol

C41H58O3S

C41H58O3S

Conditions
ConditionsYield
Stage #1: tiaprofenic acid With dicyclohexyl-carbodiimide In dichloromethane at 0℃; for 0.5h;
Stage #2: (α)-3-cholestanol With dmap In dichloromethane at 0℃; for 8h;
78%
N-(1-hydroxybutan-2-yl)nicotinamide
215120-51-7

N-(1-hydroxybutan-2-yl)nicotinamide

tiaprofenic acid
33005-95-7

tiaprofenic acid

2-(5-benzoyl-thiophen-2-yl)-propionic acid 2-[(pyridine-3-carbonyl)-amino]-butyl ester
761416-02-8

2-(5-benzoyl-thiophen-2-yl)-propionic acid 2-[(pyridine-3-carbonyl)-amino]-butyl ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In acetonitrile72%
tiaprofenic acid
33005-95-7

tiaprofenic acid

4-Methoxyphenethylamine
55-81-2

4-Methoxyphenethylamine

N1-(4-methoxyphenethyl)-2-(5-benzoyl-2-thienyl)propanamide

N1-(4-methoxyphenethyl)-2-(5-benzoyl-2-thienyl)propanamide

Conditions
ConditionsYield
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; triethylamine In N,N-dimethyl-formamide at 20℃; pH=9.0 - 9.5;70%
N-(2-hydroxyethyl)nicotinamide
6265-73-2

N-(2-hydroxyethyl)nicotinamide

tiaprofenic acid
33005-95-7

tiaprofenic acid

2-(5-benzoyl-thiophen-2-yl)-propionic acid 2-[(pyridine-3-carbonyl)-amino]-ethyl ester
761415-94-5

2-(5-benzoyl-thiophen-2-yl)-propionic acid 2-[(pyridine-3-carbonyl)-amino]-ethyl ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In acetonitrile67%
tiaprofenic acid
33005-95-7

tiaprofenic acid

methanesulfonamide
3144-09-0

methanesulfonamide

N-[2-(5-benzoyl-thiophen-2-yl)-propionyl]-methanesulfonamide

N-[2-(5-benzoyl-thiophen-2-yl)-propionyl]-methanesulfonamide

Conditions
ConditionsYield
Stage #1: tiaprofenic acid With 1,1'-carbonyldiimidazole In dichloromethane at 0 - 5℃; for 2h;
Stage #2: methanesulfonamide With 1,2-diazabicyclo[5.4.0]undec-7-ene In dichloromethane for 4h;
65%
tryptamine
61-54-1

tryptamine

tiaprofenic acid
33005-95-7

tiaprofenic acid

N1-[2-(1H-3-indolyl)ethyl]-2-(5-benzoyl-2-thienyl)propanamide

N1-[2-(1H-3-indolyl)ethyl]-2-(5-benzoyl-2-thienyl)propanamide

Conditions
ConditionsYield
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; triethylamine In N,N-dimethyl-formamide at 20℃; pH=9.0 - 9.5;60%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

tiaprofenic acid
33005-95-7

tiaprofenic acid

Tiaprofensaeure-hydroxysuccinimidester

Tiaprofensaeure-hydroxysuccinimidester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran at 0℃; for 1h;51%
tiaprofenic acid
33005-95-7

tiaprofenic acid

N-(2-hydroxypropyl)-3-pyridinecarboxamide
122048-21-9

N-(2-hydroxypropyl)-3-pyridinecarboxamide

2-(5-benzoyl-thiophen-2-yl)-propionic acid 1-methyl-2-[(pyridine-3-carbonyl)-amino]-ethyl ester
761415-98-9

2-(5-benzoyl-thiophen-2-yl)-propionic acid 1-methyl-2-[(pyridine-3-carbonyl)-amino]-ethyl ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In acetonitrile48%
tiaprofenic acid
33005-95-7

tiaprofenic acid

L-Tyr-OMe
1080-06-4

L-Tyr-OMe

methyl 2-(1-<5-benzoyl-2-thienyl>ethylcarboxamido)-3-(4-hydroxy-phenyl)propanoate

methyl 2-(1-<5-benzoyl-2-thienyl>ethylcarboxamido)-3-(4-hydroxy-phenyl)propanoate

Conditions
ConditionsYield
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; triethylamine In N,N-dimethyl-formamide for 3h; Ambient temperature;47%
tiaprofenic acid
33005-95-7

tiaprofenic acid

epicholesterol
474-77-1

epicholesterol

A

(S)-tiaprofenic acid-α-cholesterol
1019853-50-9

(S)-tiaprofenic acid-α-cholesterol

B

(R)-tiaprofenic acid-α-cholesterol
1019853-49-6

(R)-tiaprofenic acid-α-cholesterol

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 0℃; for 8h;A 37%
B 41%
tiaprofenic acid
33005-95-7

tiaprofenic acid

N-(3-hydroxypropyl)nicotinamide
53676-54-3

N-(3-hydroxypropyl)nicotinamide

2-(5-benzoyl-thiophen-2-yl)-propionic acid 3-[(pyridine-3-carbonyl)-amino]-propyl ester
761416-06-2

2-(5-benzoyl-thiophen-2-yl)-propionic acid 3-[(pyridine-3-carbonyl)-amino]-propyl ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In acetonitrile30%
tiaprofenic acid
33005-95-7

tiaprofenic acid

A

(R)-2-(5-benzoylthiophen-2-yl)propanoic acid
103667-49-8

(R)-2-(5-benzoylthiophen-2-yl)propanoic acid

B

(S)-2-(5-benzoylthiophen-2-yl)propanoic acid
103667-50-1

(S)-2-(5-benzoylthiophen-2-yl)propanoic acid

Conditions
ConditionsYield
Product distribution; pharmacokinetic parameters in humans; concentration of (R)- and (S)-enantiomers in synovial fluid and plasma;
With trifluoroacetic acid In hexane; isopropyl alcohol Reagent/catalyst; Resolution of racemate;
With isopropylamine; trifluoroacetic acid In methanol; isopropyl alcohol at 35℃; under 103432 Torr; Reagent/catalyst; Resolution of racemate; Supercritical conditions;
tiaprofenic acid
33005-95-7

tiaprofenic acid

2,6-di-tert-butylphenol
128-39-2

2,6-di-tert-butylphenol

4-<1-phenyl-1-(5-ethyl-2-thienyl)>methylidene-2,6-di-tert-butylcyclohexa-2,5-dien-1-one

4-<1-phenyl-1-(5-ethyl-2-thienyl)>methylidene-2,6-di-tert-butylcyclohexa-2,5-dien-1-one

Conditions
ConditionsYield
In acetone for 0.5h; Irradiation;31 % Chromat.
tiaprofenic acid
33005-95-7

tiaprofenic acid

L-Tyr-OMe
1080-06-4

L-Tyr-OMe

A

methyl N-[(2R)-2-(5-benzoylthien-2-yl)propanoyl]-(S)-tyrosinate

methyl N-[(2R)-2-(5-benzoylthien-2-yl)propanoyl]-(S)-tyrosinate

B

methyl N-[(2S)-2-(5-benzoylthien-2-yl)propanoyl]-(S)-tyrosinate

methyl N-[(2S)-2-(5-benzoylthien-2-yl)propanoyl]-(S)-tyrosinate

Conditions
ConditionsYield
With N-(3-dimethylaminopropyl)-N-ethylcarbodiimide Condensation;
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; triethylamine In N,N-dimethyl-formamide at 20℃; pH=9.0 - 9.5;
tiaprofenic acid
33005-95-7

tiaprofenic acid

L-tryptophan methyl ester
4299-70-1

L-tryptophan methyl ester

A

methyl N-[(2S)-2-(5-benzoylthien-2-yl)propanoyl]-3-(1H-indol-3-yl)-(S)-alaninate

methyl N-[(2S)-2-(5-benzoylthien-2-yl)propanoyl]-3-(1H-indol-3-yl)-(S)-alaninate

B

methyl N-[(2R)-2-(5-benzoylthien-2-yl)propanoyl]-3-(1H-indol-3-yl)-(S)-alaninate

methyl N-[(2R)-2-(5-benzoylthien-2-yl)propanoyl]-3-(1H-indol-3-yl)-(S)-alaninate

Conditions
ConditionsYield
With N-(3-dimethylaminopropyl)-N-ethylcarbodiimide
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; triethylamine In N,N-dimethyl-formamide at 20℃; pH=9.0 - 9.5;
tiaprofenic acid
33005-95-7

tiaprofenic acid

bovine serum albumin

bovine serum albumin

(5-ethyl-2-thienyl)phenylmethanone
6933-26-2

(5-ethyl-2-thienyl)phenylmethanone

Conditions
ConditionsYield
With saline phosphate buffer for 2h; pH=7.2; Irradiation;
tiaprofenic acid
33005-95-7

tiaprofenic acid

bovine serum albumin

bovine serum albumin

(tiaprofenic acid)-bovine serum albumin adduct

(tiaprofenic acid)-bovine serum albumin adduct

Conditions
ConditionsYield
With saline phosphate buffer; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide at 20℃; for 4h; pH=8;
With saline phosphate buffer for 2h; pH=7.2; Irradiation;
tiaprofenic acid
33005-95-7

tiaprofenic acid

rabbit serum albumin

rabbit serum albumin

(tiaprofenic acid)-rabbit serum albumin adduct

(tiaprofenic acid)-rabbit serum albumin adduct

Conditions
ConditionsYield
With saline phosphate buffer; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide at 20℃; for 4h; pH=8;
tiaprofenic acid
33005-95-7

tiaprofenic acid

2-(5-benzoyl-thiophen-2-yl)-propionic acid 2-[(1-methyl-1,4-dihydro-pyridine-3-carbonyl)-amino]-ethyl ester

2-(5-benzoyl-thiophen-2-yl)-propionic acid 2-[(1-methyl-1,4-dihydro-pyridine-3-carbonyl)-amino]-ethyl ester

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 67 percent / dicyclohexylcarbodiimide; 4-dimethylaminopyridine / acetonitrile
2: 55 percent / CH2Cl2; acetonitrile / 24 h / 20 °C
3: 52 percent / NaHCO3; Na2S2O4 / H2O; ethyl acetate / 0.25 h / 0 °C / pH 7
View Scheme
tiaprofenic acid
33005-95-7

tiaprofenic acid

3-{2-[2-(5-benzoyl-thiophen-2-yl)-propionyloxy]-ethylcarbamoyl}-1-methyl-pyridinium; iodide

3-{2-[2-(5-benzoyl-thiophen-2-yl)-propionyloxy]-ethylcarbamoyl}-1-methyl-pyridinium; iodide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 67 percent / dicyclohexylcarbodiimide; 4-dimethylaminopyridine / acetonitrile
2: 55 percent / CH2Cl2; acetonitrile / 24 h / 20 °C
View Scheme
tiaprofenic acid
33005-95-7

tiaprofenic acid

C22H21NO3S

C22H21NO3S

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 86 percent / EDC; HOBt; Et3N / dimethylformamide / 20 °C / pH 9.0 - 9.5
2: methanol / 25 °C / Flash photolysis
View Scheme
tiaprofenic acid
33005-95-7

tiaprofenic acid

C24H22N2O2S

C24H22N2O2S

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 60 percent / EDC; HOBt; Et3N / dimethylformamide / 20 °C / pH 9.0 - 9.5
2: methanol / 25 °C / Flash photolysis
View Scheme

33005-95-7Relevant articles and documents

Preparation method for tiaprofenic acid

-

, (2018/04/02)

The invention relates to a preparation method for tiaprofenic acid. The method comprises the following steps: by taking 2-thiophenecarboxaldehyde as an initial raw material, reacting with methyl magnesium bromide, thereby compounding 1-(2-thienyl) alcohol; reacting with thionyl chloride for substituting chlorine group, cyaniding and hydrolyzing; and finally, performing Friedel-Crafts acylation reaction on the acquired product and benzoyl chloride, thereby acquiring tiaprofenic acid. The preparation method for tiaprofenic acid has the advantages that the common, low-cost and safe raw materialsare adopted for replacing rare, precious and dangerous raw materials, so that the serious pollution problem is avoided and the production cost is greatly lowered, besides, the process route adopted bythe invention is simple, the reaction period is short, the reaction condition is stable, the yield is high and reaches up to 90% or above, the purity of the acquired product after the reaction is high and the purity can reach up to 99% or above, so that the preparation method is suitable for industrial production.

Synthetic process of tiaprofenic acid

-

, (2018/04/01)

The invention relates to a synthetic process of tiaprofenic acid. The synthetic process comprises the following steps: adopting 2-thiotolene as a starting raw material, enabling 2-thiotolene to reactwith trimethylsilyl cyanide to synthesize 2-thiopheneacetonitrile by virtue of bromation, then enabling the 2-thiopheneacetonitrile to react with dimethyl carbonate to be methylated, hydrolyzing cyanogroups, and finally performing F-K reaction with benzoyl chloride, and preparing tiaprofenic acid. The synthetic process has the advantages that the conventional safe raw materials low in price are used for substituting the rare expensive and dangerous raw materials, so that the severe pollution problem is avoided, and the production cost is greatly decreased; and in addition, the process route adopted by the invention is simple, the reaction period is short, the reaction condition is stable, the yield is high and can reach more than 90 percent, the produce obtained after the reaction is highin purity, and the purity can reach more than 99 percent, so that the synthetic process is suitable for the industrialized production.

Novel preparation of tiaprofenic acid

Zhang, Shuguang,Huang, Shuang,Feng, Chengliang,Cai, Jin,Chen, Junqing,Ji, Min

, p. 406 - 408 (2013/09/12)

A new synthesis of the nonsteroidal anti-inflammatory drug tiaprofenic acid starting from thiophene is described. The sequence involves five steps, and the acylation with benzoyl chloride was catalysed by zinc oxide under solventfree conditions at room temperature. This method uses a much cheaper starting material and has a higher total yield (78.4%) than other methods. It is suitable for industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 33005-95-7